C. Bath

The application of the human beta-globin gene locus control region and murine erythroleukemia cell system to the expression and pharmacological characterization of human endothelin receptor subtypes.

A. Davies, J. Brennand, E. Tang, 1995, Journal of pharmacological and toxicological methods.

New non-peptide endothelin-A receptor antagonists: synthesis, biological properties, and structure-activity relationships of 5-(dimethylamino)-N-pyridyl-,-N-pyrimidinyl-,-N-pyridazinyl-, and -N-pyrazinyl-1-naphthalenesulfonamides.

R. Bradbury, A. Mortlock, M. Dennis, 1997, Journal of medicinal chemistry.

N-Methyl-2-[4-(2-methylpropyl)phenyl]-3-(3-methoxy-5-methylpyrazin-2-ylsulfamoyl)benzamide; one of a class of novel benzenesulphonamides which are orally-active, ETA-selective endothelin antagonists

A. Mortlock, N. D. Wright, R. Butlin, 1997 .

New Non-Peptide Endothelin-A Receptor Antagonists: Synthesis, Biological Properties, and Structure-Activity Relationships of 5-( Dimethylamino)-N-pyridyl-, -N-pyrimidinyl-, -N-pyridazinyl-, and -N- pyrazinyl-1-naphthalenesulfonamides.

R. Bradbury, A. Mortlock, M. Dennis, 1997 .